Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)
PHASE2CompletedINTERVENTIONAL
Enrollment
15
Participants
Timeline
Start Date
August 31, 2006
Study Completion Date
October 31, 2007
Conditions
Carcinoma, Hepatocellular
Interventions
DRUG
Capecitabine in HCC
Trial Locations (1)
74800
Aga Khan University, Karachi
All Listed Sponsors
lead
Aga Khan University
OTHER
NCT00464295 - Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC) | Biotech Hunter | Biotech Hunter